动脉静脉囊狭窄症中的外体
Yushi Cao1, Fangxiao Guo2, Dandan Chen3
1School of Biological Science and Medical Engineering, Beihang University, Beijing, China.
Frontiers in cell and developmental biology
|October 6, 2025
概括
动脉静脉囊 (AVF) 狭窄症涉及静脉内膜增生. 外体,携带生物分子,是细胞通信的关键,并显示出诊断和治疗AVF狭窄的潜力.
科学领域:
- 血管生物学 血管生物学
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
背景情况:
- 动脉静脉 (AVF) 狭窄是由于静脉内膜增生引起的.
- 影响AVF狭窄的因素包括手术损伤,血液动力学,炎症和细胞增殖.
- 外体通过生物分子调解细胞间的通信,影响与血管疾病相关的细胞功能.
研究的目的:
- 审查在动脉静脉囊 (AVF) 狭窄症中对外体的应用.
- 要突出外体源分子在AVF狭窄病原发生中的作用.
- 探索外体在AVF狭窄症中的诊断和治疗潜力.
主要方法:
- 对外体和AVF狭窄的研究的文献综述.
- 对外体载荷 (DNA,RNA,蛋白质,微RNA) 和它们的功能进行分析.
- 评估外体作为生物标志物和药物输送载体的评估.
主要成果:
- 外体内含有调节内皮细胞和平滑肌肉细胞行为的生物分子.
- 外体体内的微RNA与血管狭窄的发展有关.
- 外体体显示出作为诊断生物标志物和针对AVF狭窄的向药物载体的潜力.
结论:
- 外体在AVF狭窄的发病过程中起着重要作用.
- 外体为诊断和治疗AVF狭窄提供了有前途的途径.
- 对基于外体的治疗方法的进一步研究可能会彻底改变AVF狭窄症的管理.
相关概念视频
01:25Hemodialysis I: Introduction
1.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.3K
01:36Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K